ACAD CIK: 1070494

Acadia Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−126
FY22:
−114
FY23:
16.7
FY24:
158
FY25:
110
Change from FY21 to FY25
millions USD
FY21:
−71.1
FY22:
73.2
FY23:
32.0
FY24:
−30.5
FY25:
−303
Change from FY21 to FY25
millions USD
FY21:
18.2
FY22:
8.20
FY23:
25.1
FY24:
6.85
FY25:
49.9
millions USD
FY21:
−179
FY22:
−32.6
FY23:
73.8
FY24:
134
FY25:
−143
(positive)
Change from FY21 to FY25
millions USD
FY21:
−127
FY22:
−114
FY23:
16.7
FY24:
157
FY25:
105

All amounts in millions USD Data source:SEC EDGAR